Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Lanting Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3442-2773; OpenAlex author ID A5004106361. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 3 papers · 2023: 3 papers

Papers 7

  1. Preoperative Extrapancreatic Extension Prediction in Patients with Pancreatic Cancer Using Multiparameter MRI and Machine Learning-Based Radiomics Model. Co-author DOI 10.1016/j.acra.2022.09.017↗
  2. Identification of m7G-Related LncRNA Signature for Predicting Prognosis and Evaluating Tumor Immune Infiltration in Pancreatic Adenocarcinoma. Co-author DOI 10.3390/diagnostics13101697↗
  3. Suppression of Wnt/β-catenin Signaling in PDAC via METTL16-mediated N6-methyladenosine Modification of DVL2. Co-author DOI 10.7150/jca.85860↗
  4. Circular RNA circ_0047744 suppresses the metastasis of pancreatic ductal adenocarcinoma by regulating the miR-21/SOCS5 axis. Co-author DOI 10.1016/j.bbrc.2022.03.082↗
  5. Identification and Validation of Prognostic Model for Pancreatic Ductal Adenocarcinoma Based on Necroptosis-Related Genes. Co-author DOI 10.3389/fgene.2022.919638↗
  6. RELA-induced MiR-21 Exerts Oncogenic Effects on PDAC via Targeting of ARHGAP24. Co-author DOI 10.7150/jca.73690↗
  7. miR-21 promotes EGF-induced pancreatic cancer cell proliferation by targeting Spry2. Co-author DOI 10.1038/s41419-018-1182-9↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ni Xie · 6 shared papers, 2022–2023 · strength 1.08
  2. Baiwen Li · 6 shared papers, 2018–2023 · strength 0.98
  3. Haoran Xie · 3 shared papers, 2022 · strength 0.48
  4. Qiuyan Zhao · 3 shared papers, 2018–2022 · strength 0.40
  5. Xingpeng Wang · 2 shared papers, 2022–2023 · strength 0.34
  6. Jiawei Lu · 1 shared paper, 2023 · strength 0.22
  7. Hao Liu · 1 shared paper, 2023 · strength 0.18
  8. Xuhui Fan · 1 shared paper, 2023 · strength 0.18
  9. Baiwen Li · 1 shared paper, 2023 · strength 0.18
  10. Li Cheng · 1 shared paper, 2022 · strength 0.16
  11. Zhonglin Zhu · 1 shared paper, 2018 · strength 0.09
  12. Mingjie Jiang · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.